Dysregulation of the circRNA_0087207/miR-548c-3p/PLSR1-TGFB2 axis in Leber’s hereditary optic neuropathy in vitro

Author:

Yang Yi-Ping12,Chang Yuh-Lih34,Chiou Guang-Yuh56,Lee Meng-Shiue7,Wu You-Ren128,Chen Po-Wei34,Lin Yi-Ying12,Lai Wei-Yi12,Liu Yu-Hao12,Hwang De-Kuang19,Chien Yueh12

Affiliation:

1. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC

2. Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC

3. Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan,ROC

4. Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC

5. Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan, ROC

6. Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu, Taiwan, ROC

7. Institute of Molecular Medicine and Bioengineering, National Yang Ming Chiao Tung University, Hsinchu, Taiwan, ROC

8. Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC

9. Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC

Abstract

Background: Leber’s hereditary optic neuropathy (LHON) is mainly the degeneration of retinal ganglion cells (RGCs) associated with high apoptosis and reactive oxygen species (ROS) levels, which is accepted to be caused by the mutations in the subunits of complex I of the mitochondrial electron transport chain. The treatment is still infant while efforts of correcting genes or using antioxidants do not bring good and consistent results. Unaffected carrier carries LHON mutation but shows normal phenotype, suggesting that the disease’s pathogenesis is complex, in which secondary factors exist and cooperate with the primary complex I dysfunction. Methods: Using LHON patient-specific induced pluripotent stem cells (iPSCs) as the in vitro disease model, we previously demonstrated that circRNA_0087207 had the most significantly higher expression level in the LHON patient-iPSC-derived RGCs compared with the unaffected carrier-iPSC-derived RGCs. To elaborate the underlying pathologies regulated by circRNA_008720 mechanistically, bioinformatics analysis was conducted and elucidated that circRNA_0087207 could act as a sponge of miR-548c-3p and modulate PLSCR1/TGFB2 levels in ND4 mutation-carrying LHON patient iPSC-derived RGCs. Results: Using LHON iPSC-derived RGCs as the disease-based platform, KEGG pathway analysis on targeted mRNA of miR-548c-3p showed the connection with apoptosis, suggesting downregulation of miR548c-3p contributes to the apoptosis of LHON patient RGCs. Conclusion: We showed that the downregulation of miR548c-3p plays a critical role in modulating cellular dysfunction and the apoptotic program of RGCs in LHON.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3